Initially, both Hs578T and MDA-MB-231 cell lines were classified as triple-negative breast cancer (TNBC) cells, characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.